Omega Diagnostics advances on virus antibody home test kit hopes
Shares in diagnostics company Omega Diagnostics (ODX:AIM) advanced 3.5% to 64.2p on Tuesday after its partner Abingdon Health (ABDX:AIM) provided an update on the government's Rapid Test Consortium (RTC).Abingdon's shares, which listed on the AIM market on 15 December at 92p, were unchanged at 95p.SELF-ADMINISTERED ANTIBODY TEST The UK-RTC was formed in April to develop and manufacture a...